Industrial Bioprocessing Global Market Report 2026

Industrial bioprocessing is an industrial manufacturing process that uses biological systems such as microorganisms, enzymes, or living cells to carry out controlled biological reactions at a commercial scale. It involves the integration of biotechnology, process engineering, and monitoring systems to improve production efficiency, process consistency, and operational sustainability.

The primary types of industrial bioprocessing include upstream processing, downstream processing, process analytical technologies, and bioprocess consumables and accessories. Upstream processing refers to the initial stages of biomanufacturing that involve the cultivation, growth, and maintenance of microorganisms or cells used to produce biological products. These processes utilize technologies such as fermentation, biocatalysis, cell culture, and other technologies. The various applications involved are biopharmaceutical production, industrial enzymes, biofuels, food and beverage processing, wastewater treatment, and agricultural biotechnology, and they are used by several end users such as industrial, commercial, and residential end users.

Tariffs are influencing the industrial bioprocessing market by increasing the cost of imported bioreactors, chromatography systems, single-use consumables, and advanced downstream processing equipment required for large-scale biological production. This is leading to higher capital expenditure and operational delays, particularly in regions dependent on imports such as Asia-Pacific and Latin America, where biopharmaceutical and industrial enzyme production are expanding rapidly. Upstream and downstream processing segments are most affected due to reliance on specialized global supply chains. However, tariffs are also encouraging localization of manufacturing, regional supplier development, and increased investment in domestic bioprocessing infrastructure, ultimately strengthening long-term production resilience and supply security.

The industrial bioprocessing market size has grown strongly in recent years. It will grow from $18.95 billion in 2025 to $20.61 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to growth in pharmaceutical manufacturing demand, expansion of industrial enzyme production, increasing adoption of fermentation based processes, rising investments in biotechnology research facilities, development of large scale biomanufacturing infrastructure.

The industrial bioprocessing market size is expected to see strong growth in the next few years. It will grow to $29.05 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to rising demand for bio based chemicals and fuels, expansion of precision medicine and biologics production, increasing focus on cost efficient biomanufacturing processes, adoption of next generation cell culture technologies, growing demand for sustainable industrial production alternatives. Major trends in the forecast period include increasing adoption of single use bioprocessing systems for reduced contamination risk, rising demand for high efficiency downstream purification techniques, expansion of large scale fermentation capacity in industrial manufacturing, growing preference for modular and flexible bioreactor designs, increasing focus on regulatory compliant bio production workflows ensuring product consistency.

The rising demand for biologics and biopharmaceuticals is expected to propel the growth of the industrial bioprocessing market going forward. Biologics and biopharmaceuticals are complex therapeutic products developed using living cells or organisms to treat a wide range of medical conditions through biological pathways. The demand for biologics and biopharmaceuticals is increasing due to the growing prevalence of chronic diseases, as these advanced therapies offer highly targeted and effective treatment options with improved clinical outcomes compared to traditional medications. Industrial bioprocessing supports biologics and biopharmaceuticals production by enabling the large-scale cultivation of cells and microorganisms required to manufacture complex biological medicines efficiently, consistently, and with high purity through controlled fermentation and downstream processing methods. For instance, in January 2023, according to Cardinal Health Inc., a US-based healthcare company, the United States had 33 FDA-approved biosimilar products as of January 2022, of which 21 were commercially available. By 2023, the number of FDA-approved biosimilars had increased to 40, with 25 available in the market. Therefore, the rising demand for biologics and biopharmaceuticals is driving the growth of the industrial bioprocessing market.

Major companies operating in the industrial bioprocessing market are focusing on establishing strategic partnerships to improve upstream processing efficiency, accelerate process intensification, and enhance biomanufacturing productivity. Strategic partnerships are collaborative arrangements between organizations that combine technologies, expertise, and resources to drive innovation, improve operational performance, and expand capabilities in industrial bioprocessing. For instance, in August 2023, Sartorius AG, a Germany-based life sciences company, partnered with Repligen Corporation, a US-based bioprocessing technology company, to introduce an integrated solution that combines the Biostat STR bioreactor with XCell ATF technology for upstream process intensification. The system is designed to support high-density cell culture and intensified perfusion processes, increasing productivity and efficiency in industrial bioprocessing applications used in the manufacture of biologics, including monoclonal antibodies and other therapeutic proteins.

In August 2024, Merck KGaA, a Germany-based science and technology company, acquired Mirus Bio LLC for $600 million. Through this acquisition, Merck KGaA sought to strengthen its viral vector bioprocessing capabilities, broaden its cell and gene therapy manufacturing portfolio, and enhance its end-to-end solutions for advanced biologics production. Mirus Bio LLC is a US-based biotechnology company that provides upstream bioprocessing solutions for cell and gene therapy manufacturing.

Major companies operating in the industrial bioprocessing market are Thermo Fisher Scientific; Danaher Corporation; Merck KGaA; Sartorius Aktiengesellschaft; Avantor Inc.; Corning Inc.; GEA Group Aktiengesellschaft; Repligen Corporation; Entegris Inc.; Eppendorf SE; Parker Hannifin; Hamilton Company; ZETA Holding GmbH; Glatt Ingenieurtechnik GmbH; Rentschler Biopharma SE; Meissner Filtration Products Inc.; Shanghai Tofflon Science and Technology Co. Ltd.; ABEC Inc.; Codexis Inc.; PBS Biotech Inc.; Broadley-James Corporation; INFORS HT; CerCell ApS; Wacker Biotech GmbH; BPC Instruments AB; OmniBRx Biotechnologies Pvt. Ltd.; Bailun Biotechnology Co. Ltd.; Adolf Kuhner AG; Fermenter Technologies Pty Ltd

North America was the largest region in the industrial bioprocessing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the industrial bioprocessing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the industrial bioprocessing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The industrial bioprocessing market consists of revenues earned by entities by providing services such as cell line development, bioprocess scale-up services, and technology transfer services. The market value includes the value of related goods sold by the service provider or included within the service offering. The industrial bioprocessing market also includes sales of bioreactors and fermenters, filtration systems, and single-use bioprocessing systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The industrial bioprocessing market research report is one of a series of new reports from The Business Research Company that provides industrial bioprocessing market statistics, including industrial bioprocessing industry global market size, regional shares, competitors with a industrial bioprocessing market share, detailed industrial bioprocessing market segments, market trends and opportunities, and any further data you may need to thrive in the industrial bioprocessing industry. This industrial bioprocessing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Industrial Bioprocessing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses industrial bioprocessing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for industrial bioprocessing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The industrial bioprocessing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Upstream Processing; Downstream Processing; Process Analytical Technologies; Bioprocess Consumables And Accessories
• 2) By Technology: Fermentation; Biocatalysis; Cell Culture; Other Technologies
• 3) By Application: Biopharmaceutical Production; Industrial Enzymes; Biofuels; Food And Beverage Processing; Wastewater Treatment; Agricultural Biotechnology
• 4) By End User: Industrial; Commercial; Residential
• Subsegments:
• 1) By Upstream Processing: Cell Culture Media; Buffer Solutions; Bioreactors; Fermentation Systems; Filtration Systems; Cell Separation Equipment; Sensors And Monitoring Devices
• 2) By Downstream Processing: Chromatography Systems; Filtration Technologies; Centrifugation Equipment; Drying Equipment; Purification Resins; Separation Membranes; Concentration Systems
• 3) By Process Analytical Technologies: Spectroscopy Systems; Chromatography Analyzers; Particle Size Analyzers; Biomass Monitoring Systems; Gas Analysis Systems; Ph Measurement Systems; Data Management Software
• 4) By Bioprocess Consumables And Accessories: Single Use Bags; Filters; Tubing Assemblies; Culture Media; Reagents; Sampling Devices; Connectors And Fittings
• Companies Mentioned: Thermo Fisher Scientific; Danaher Corporation; Merck KGaA; Sartorius Aktiengesellschaft; Avantor Inc.; Corning Inc.; GEA Group Aktiengesellschaft; Repligen Corporation; Entegris Inc.; Eppendorf SE; Parker Hannifin; Hamilton Company; ZETA Holding GmbH; Glatt Ingenieurtechnik GmbH; Rentschler Biopharma SE; Meissner Filtration Products Inc.; Shanghai Tofflon Science and Technology Co. Ltd.; ABEC Inc.; Codexis Inc.; PBS Biotech Inc.; Broadley-James Corporation; INFORS HT; CerCell ApS; Wacker Biotech GmbH; BPC Instruments AB; OmniBRx Biotechnologies Pvt. Ltd.; Bailun Biotechnology Co. Ltd.; Adolf Kuhner AG; Fermenter Technologies Pty Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.